Soyeon Bak1,2, Kyoung Sub Kim1, Kun Na3,4

  • 1Department of Biomedical-Chemical Engineering, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea.

Cancer gene therapy
|June 10, 2024
PubMed
概括

工程干细胞诱导亡,一个被编程的细胞死亡,触发对瘤的免疫反应. 这种新的方法通过刺激细胞毒性T细胞,显示出有效的抗癌免疫疗法的前景.